ABSTRACT
INTRODUCTION
collagen which leads to tubulointerstitial fibrosis. Tubular epithelial cell apoptosis may be due 79 to the direct effect of the CNI or from local hypoxia due to renal vasoconstriction (8, 17, 34, 40, 80 49). The foregoing suggests that CNI-induced nephrotoxicity occurs via a multifactorial 81 mechanism and, therefore, in order to be effective in preventing or treating these CNI-induced 82 complications, potential therapeutic agents will need to have broad-based modulating effects on 83 vascular tone, inflammation, oxidative stress and apoptosis. Such an agent would allow patients 84 to benefit from these useful drugs while preventing overt complications. Immunohistochemistry and TUNEL assay 159 Formalin-fixed kidneys were embedded in paraffin and used for immunohistochemical studies.
160
After routine deparaffinization, heat-induced epitope retrieval was done using a citrate-based 161 buffer. Endogenous peroxidase was quenched by incubation with 3% H 2 O 2 in phosphate-162 buffered saline (PBS; pH 7.4) for 5 min. The sections were permeabilized using 0.1% (wt/vol) 163 Triton X-100 in PBS for 15 min. Nonspecific binding was minimized by incubating sections 164 with 5% normal serum from the species in which the secondary antibody was raised (diluted in 165 5% bovine serum albumin/PBS) for 60 min at room temperature. Endogenous biotin and avidin 166 binding sites were blocked by sequential incubation with avidin and biotin for 15 min (Vector 167 Laboratories, Burlingame, CA, USA). The primary antibodies used to detect GRP78/BiP, C/EBP 168 homologous protein (CHOP) and CD68 were goat anti-rat GRP78 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-rat CHOP (Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
Cell Cultures

212
The well-characterized normal rat proximal tubular epithelial cell line, NRK-52E, was obtained 
RESULTS
249
PVPA Prevents the Development of Hypertension in CSA Treated Rats
250
Hypertension is a common complication in patients who receive calcineurin inhibitor treatment 251 and this has been associated with increased cardiovascular morbidity and mortality, as well as 252 graft loss in renal transplant recipients (7, 27, 38) . To investigate whether PVPA affected the 253 development of hypertension in an experimental model of CSA-induced nephrotoxicity, we 254 measured SBP in conscious male Sprague Dawley rats by the non-invasive tail-cuff method.
255
Baseline SBP was not different between the three groups of rats. Consistent with the known 256 effect of CSA on blood pressure, the animals developed robust hypertension by day 7 of CSA 257 treatment with an increase in SBP of 33±4 mmHg (P < 0.001), followed by a steady rise in SBP Figure 2B ). Importantly, at the end of the study, no differences in urinary 278 sodium and potassium excretion rates were noted in the CSA-only group versus the PVPA group 279 (Sodium: 0.60 ± 0.08 vs 0.79 ± 0.08 mmol/day, P = 0.14; Potassium, 1.68 ± 0.12 vs 1.74 ± 0.18 280 mmol/day, P = 0.8). This indicates that salt intake was similar between the CSA-only and PVPA 281 rats. Altogether, these data imply that the reduction in albuminuria and proteinuria in the PVPA to oxidative stress which is associated with cellular apoptosis, tissue inflammation and fibrosis.
308
Oxidative stress has been shown to be an important mediator of CSA-induced nephrotoxicity.
309
We evaluated whether PVPA administration modifies oxidative stress during CSA treatment.
310
The level of thiobarbituric acid-reactive substances (TBARS), a measure of ROS levels, was 311 significantly increased by 60-80% in the cortex and medulla after CSA treatment compared with kidney tissues using immunohistochemical analysis. We found more than a 2-fold increase in GRP78 expression in both the cortex and medulla consistent with increased ER stress following
352
CSA treatment compared with control rats. The co-administration of PVPA to CSA-treated rats 353 downregulated GRP78 expression levels by more than 50% ( Figure 7A, B) . Similarly, the 354 expression level of the pro-apoptotic transcription factor CHOP was upregulated by 1.6-2.8 fold
355
in the cortex and medulla in CSA-treated rats and co-treatment with PVPA significantly for EETs in this model and the findings suggest that the cytochrome P-450/EET system may 404 offer a novel multi-mechanism therapeutic strategy to prevent CNI-induced nephrotoxicity.
405
The mechanism of CNI-induced hypertension and nephrotoxicity is complex and remains All these are precursors to the development of fibrosis during chronic administration of 452 cyclosporine (30), and these changes were all ameliorated by co-administration of PVPA.
453
Following 28 days of CSA administration to the animals, we found evidence of ER stress in 454 tubular epithelial cells as depicted by the marked increase in expression of the master chaperone,
455
GRP 78, and also the transcription factor, CHOP, which is associated with apoptotic cell death. 
